Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Chemotherapy-induced Neutropenia
Interventions: DRUG: rHSA-GCSF 2.4mg|DRUG: GCSF
Sponsor: Tianjin SinoBiotech Ltd.